SBMFF (Sino Biopharmaceutical) Dividend Payout Ratio: 1.00 (As of Dec. 2025) — 270% Above Median


SBMFF Sino Biopharmaceutical Ltd SBMFF
61 GF Score
Price $0.60
GF Value $0.65
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sino Biopharmaceutical Dividend Payout Ratio?

Sino Biopharmaceutical SBMFF -4.96% 61 Dividend Payout Ratio is 1.00 as of Dec. 2025, which is 270% above its 10-year median of 0.27. GuruFocus rates SBMFF with a GF Score™ of 61/100 and a GF Value™ of $0.65 (Fairly Valued). The stock has 4 warning signs investors should review. Among 134 Biotechnology companies, Sino Biopharmaceutical ranks better than 55.22% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sino Biopharmaceutical's Dividend Payout Ratio for the months ended in Dec. 2025 was 1.00.

The historical rank and industry rank for Sino Biopharmaceutical's Dividend Payout Ratio or its related term are showing as below:

SBMFF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05   Med: 0.27   Max: 0.75
Current: 0.38

During the past 13 years, the highest Dividend Payout Ratio of Sino Biopharmaceutical was 0.75. The lowest was 0.05. And the median was 0.27.

SBMFF's Dividend Payout Ratio is ranked better than
55.22% of 134 companies
in the Biotechnology industry
Industry Median: 0.445 vs SBMFF: 0.38

As of today (2026-07-01), the Dividend Yield % of Sino Biopharmaceutical is 2.13%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Sino Biopharmaceutical was 3.63%. The lowest was 0.37%. And the median was 0.87%.

Sino Biopharmaceutical's Dividends per Share for the months ended in Dec. 2025 was $0.01.

During the past 12 months, Sino Biopharmaceutical's average Dividends Per Share Growth Rate was 54.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -2.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 15.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sino Biopharmaceutical was 58.70% per year. The lowest was -20.60% per year. And the median was 12.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sino Biopharmaceutical (OTCPK:SBMFF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sino Biopharmaceutical Dividend Payout Ratio Related Terms

Sino Biopharmaceutical Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Sino Biopharmaceutical's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sino Biopharmaceutical Dividend Payout Ratio Chart

Sino Biopharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.71 0.67 0.31 0.43

Sino Biopharmaceutical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.36 0.29 0.22 1.00

SBMFF vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Sino Biopharmaceutical's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Dividend Payout Ratio falls into.


SBMFF
61GF Score
Sino Biopharmaceutical Ltd SBMFF
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sino Biopharmaceutical Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Sino Biopharmaceutical's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.012/ 0.028
=0.43

Sino Biopharmaceutical's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0.006/ 0.006
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 1.00 mean?
Sino Biopharmaceutical (SBMFF) has a Dividend Payout Ratio of 1.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sino Biopharmaceutical and its competitors. This is 270% above median its historical median of 0.27. Over the past decade, Sino Biopharmaceutical's Dividend Payout Ratio has ranged from 0.05 to 0.75. According to the industry distribution chart, Sino Biopharmaceutical ranks #60 out of 134 companies in the Biotechnology industry, placing it in the top 44.8%.
Is Sino Biopharmaceutical's Dividend Payout Ratio too high?
Sino Biopharmaceutical's current Dividend Payout Ratio of 1.00 is 270% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.75. The Biotechnology industry median Dividend Payout Ratio is 0.45. Sino Biopharmaceutical's value of 1.00 is 124.7% above this industry median. Based on the distribution chart, Sino Biopharmaceutical ranks #60 out of 134 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sino Biopharmaceutical has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sino Biopharmaceutical's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sino Biopharmaceutical ranks #60 out of 134 companies for Dividend Payout Ratio. This puts Sino Biopharmaceutical in the upper half of its industry. The industry median Dividend Payout Ratio is 0.45. Sino Biopharmaceutical's value of 1.00 is 124.7% above this benchmark. Historically, Sino Biopharmaceutical's own Dividend Payout Ratio has ranged from 0.05 to 0.75 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 0.45, Sino Biopharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Biopharmaceutical's current Dividend Payout Ratio of 1.00 is 124.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sino Biopharmaceutical and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Biopharmaceutical's current Dividend Payout Ratio is 1.00, which is 270% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Biopharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Sino Biopharmaceutical (SBMFF) is currently considered Fairly Valued. The stock's GF Value™ is $0.65, compared to a current price of $0.60 — trading 7.4% below its estimated fair value. The current Dividend Payout Ratio is 1.00, which is 270% above median its 10-year median of 0.27 and 124.7% above the Biotechnology industry median of 0.45. Sino Biopharmaceutical's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Sino Biopharmaceutical (SBMFF), the current Dividend Payout Ratio is 1.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?

Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued. The current stock price of $0.60 is trading 7.4% below its estimated GF Value™ of $0.65. GuruFocus considers Sino Biopharmaceutical to be Fairly Valued.

Key valuation signals for SBMFF:

  • Dividend Payout Ratio: 1.00 (270% above median its 10-year median of 0.27)
  • GF Value™: $0.65 vs. price of $0.60 (7.4% below fair value)
  • GF Score™: 61/100 with 4 warning signs
  • Industry Position: 124.7% above the Biotechnology median (#60 of 134)

No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sino Biopharmaceutical Business Description

Address 1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
61GF Score

Get the complete analysis for SBMFF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price
$0.65
GF Value